skip to main content
10.1145/3589437.3589442acmotherconferencesArticle/Chapter ViewAbstractPublication PagesiccbbConference Proceedingsconference-collections
research-article

Research on Cell Aging Based on Reprogramming Senescent Cells by Inhibiting Pro-Inflammatory TNF/Edn1 Pathway as a Potential Treatment of Age-Related Diseases

Published:20 July 2023Publication History

ABSTRACT

Aging is the process of progressive cellular senescence and tissue degeneration that eventually leads to organismal death. This degeneration manifests itself in the forms of various age-related diseases, such as neurodegenerative disorders, diabetes, and chronic inflammation. Although initially believed to be the inevitable final fate of human life, mounting evidence demonstrate the possibility to extend lifespan and decelerate the process of aging. From these observations, the question of whether aging can be reversed through cellular rejuvenation inspires further research. In humans, germline cells activate a natural program of rejuvenation in fertilization events, suggesting the possibility of cellular age reversal. While the nuance of the underlying mechanism is unclear, reprogramming the epigenome during aging seems to play central role.This project aims to identify candidate age reprogramming genes as alternatives to OSKM through directly comparing senescent and young cells (with gene expression data from human bone marrow-derived stromal cells, mouse retinal ganglion cells, and mouse fibroblasts).

References

  1. Ferrell JE, Jr. Bistability, bifurcations, and Waddington's epigenetic landscape. Curr Biol. 2012;22(11):R458-66.Google ScholarGoogle Scholar
  2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76.Google ScholarGoogle Scholar
  3. Ocampo A, Reddy P, Martinez-Redondo P, Platero-Luengo A, Hatanaka F, Hishida T, In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167(7):1719-33 e12.Google ScholarGoogle Scholar
  4. Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588(7836):124-9.Google ScholarGoogle Scholar
  5. Mahmoudi S, Mancini E, Xu L, Moore A, Jahanbani F, Hebestreit K, Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing. Nature. 2019;574(7779):553-8.Google ScholarGoogle Scholar
  6. Sarkar TJ, Quarta M, Mukherjee S, Colville A, Paine P, Doan L, Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 2020;11(1):1545.Google ScholarGoogle Scholar
  7. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-217.Google ScholarGoogle Scholar
  8. Soria-Valles C, Lopez-Otin C. iPSCs: On the Road to Reprogramming Aging. Trends Mol Med. 2016;22(8):713-24.Google ScholarGoogle Scholar
  9. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 2007;21(24):3244-57.Google ScholarGoogle Scholar
  10. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000;102(19):2434-40.Google ScholarGoogle ScholarCross RefCross Ref
  11. Rosano L, Spinella F, Bagnato A. Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2013;13(9):637-51.Google ScholarGoogle Scholar
  12. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247-55.Google ScholarGoogle Scholar
  13. Yeager ME, Belchenko DD, Nguyen CM, Colvin KL, Ivy DD, Stenmark KR. Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 2012;46(1):14-22.Google ScholarGoogle Scholar
  14. Scalera F, Dittrich R, Beckmann MW, Beinder E. Effect of endothelin-1 on intracellular glutathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial cells. Eur J Clin Invest. 2002;32(8):556-62.Google ScholarGoogle Scholar
  15. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol. 2005;145(3):323-33.Google ScholarGoogle Scholar
  16. Singh PB, Newman AG. Age reprogramming and epigenetic rejuvenation. Epigenetics Chromatin. 2018;11(1):73.Google ScholarGoogle Scholar
  17. Kerepesi C, Zhang B, Lee SG, Trapp A, Gladyshev VN. Epigenetic clocks reveal a rejuvenation event during embryogenesis followed by aging. Sci Adv. 2021;7(26).Google ScholarGoogle Scholar
  18. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.Google ScholarGoogle Scholar
  19. Sanese P, Forte G, Disciglio V, Grossi V, Simone C. FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs. Comput Struct Biotechnol J. 2019;17:737-45.Google ScholarGoogle Scholar
  20. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69 Suppl 1:S4-9.Google ScholarGoogle Scholar
  21. Maguire JJ, Davenport AP. Endothelin receptors and their antagonists. Semin Nephrol. 2015;35(2):125-36.Google ScholarGoogle Scholar
  22. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, Fukami T, In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol. 1992;20 Suppl 12:S11-4.Google ScholarGoogle Scholar
  23. Ford RL, Mains IM, Hilton EJ, Reeves ST, Stroud RE, Crawford FA, Jr., Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation. Ann Thorac Surg. 2008;86(5):1576-83.Google ScholarGoogle Scholar
  24. Chen Y, Hanaoka M, Droma Y, Chen P, Voelkel NF, Kubo K. Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats. Eur Respir J. 2010;35(4):904-12.Google ScholarGoogle Scholar
  25. Xu H, Lin L, Yuan WJ. Antiarrhythmic effect of endothelin-A receptor antagonist on acute ischemic arrhythmia in isolated rat heart. Acta Pharmacol Sin. 2003;24(1):37-44.Google ScholarGoogle Scholar
  26. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994;91(11):4892-6.Google ScholarGoogle Scholar
  27. Tonari M, Kurimoto T, Horie T, Sugiyama T, Ikeda T, Oku H. Blocking endothelin-B receptors rescues retinal ganglion cells from optic nerve injury through suppression of neuroinflammation. Invest Ophthalmol Vis Sci. 2012;53(7):3490-500.Google ScholarGoogle Scholar
  28. Piechota-Polanczyk A, Kleniewska P, Goraca A. The influence of ETA and ETB receptor blockers on LPS-induced oxidative stress and NF-kappaB signaling pathway in heart. Gen Physiol Biophys. 2012;31(3):271-8.Google ScholarGoogle Scholar
  29. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol. 2006;69(4):1347-55.Google ScholarGoogle Scholar
  30. Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging (Albany NY). 2015;7(1):26-37.Google ScholarGoogle Scholar
  31. Ratajczak J, Shin DM, Wan W, Liu R, Masternak MM, Piotrowska K, Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice–novel view on Igf-1, stem cells and aging. Leukemia. 2011;25(4):729-33.Google ScholarGoogle Scholar
  32. Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018;52(7):751-62.Google ScholarGoogle Scholar
  33. Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med. 2021;11(3):e372.Google ScholarGoogle Scholar
  34. Kumar P, Osahon OW, Sekhar RV. GlyNAC (Glycine and N-Acetylcysteine) Supplementation in Mice Increases Length of Life by Correcting Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Abnormalities in Mitophagy and Nutrient Sensing, and Genomic Damage. Nutrients. 2022;14(5).Google ScholarGoogle Scholar

Index Terms

  1. Research on Cell Aging Based on Reprogramming Senescent Cells by Inhibiting Pro-Inflammatory TNF/Edn1 Pathway as a Potential Treatment of Age-Related Diseases

    Recommendations

    Comments

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Sign in
    • Published in

      cover image ACM Other conferences
      ICCBB '22: Proceedings of the 2022 6th International Conference on Computational Biology and Bioinformatics
      December 2022
      87 pages
      ISBN:9781450397636
      DOI:10.1145/3589437

      Copyright © 2022 ACM

      Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].

      Publisher

      Association for Computing Machinery

      New York, NY, United States

      Publication History

      • Published: 20 July 2023

      Permissions

      Request permissions about this article.

      Request Permissions

      Check for updates

      Qualifiers

      • research-article
      • Research
      • Refereed limited
    • Article Metrics

      • Downloads (Last 12 months)22
      • Downloads (Last 6 weeks)0

      Other Metrics

    PDF Format

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    HTML Format

    View this article in HTML Format .

    View HTML Format